Analyst Research

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Pechala's Reports
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott announces FDA clearance for a new test to help physicians quickly and accurately diagnose diabetes


Monday, 14 Apr 2014 09:00am EDT 

Abbott Laboratories:Says that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test - which can aid physicians in diagnosing and monitoring diabetes and identifying people at risk for the disease - has received 510 clearance from the U.S. Food and Drug Administration. 

Company Quote

37.41
-0.6 -1.58%
5 Feb 2016